Trial · NCT02500043
Adverse events934
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 934
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | TAS-102+BSC | 142 | 335 | 249 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo+BSC | 30 | 168 | 52 |
| other | Bone marrow failure | Blood and lymphatic system disorders | TAS-102+BSC | 1 | 335 | 1 |
| other | Bone marrow failure | Blood and lymphatic system disorders | Placebo+BSC | 0 | 168 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | TAS-102+BSC | 1 | 335 | 1 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Placebo+BSC | 0 | 168 | 0 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | TAS-102+BSC | 2 | 335 | 2 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Placebo+BSC | 0 | 168 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | TAS-102+BSC | 57 | 335 | 116 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo+BSC | 3 | 168 | 14 |
| other | Lymph node pain | Blood and lymphatic system disorders | TAS-102+BSC | 1 | 335 | 1 |
| other | Lymph node pain | Blood and lymphatic system disorders | Placebo+BSC | 0 | 168 | 0 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | TAS-102+BSC | 0 | 335 | 0 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Placebo+BSC | 1 | 168 | 1 |
| other | Lymphopenia | Blood and lymphatic system disorders | TAS-102+BSC | 20 | 335 | 42 |
| other | Lymphopenia | Blood and lymphatic system disorders | Placebo+BSC | 8 | 168 | 21 |
| other | Neutropenia | Blood and lymphatic system disorders | TAS-102+BSC | 128 | 335 | 312 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo+BSC | 6 | 168 | 9 |
| other | Neutrophilia | Blood and lymphatic system disorders | TAS-102+BSC | 0 | 335 | 0 |
| other | Neutrophilia | Blood and lymphatic system disorders | Placebo+BSC | 1 | 168 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02500043/events